Home > Site map > Report overview

Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers

Published by: Venture Planning Group

Published: Jun. 1, 2011 - 1050 Pages

Introduction
Worldwide Market And Technology Overview: A. DNA Sequencing; B. DNA And RNA Probe Technology; C. Detection Technologies; D. Instrumentation Review; E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip; F. Pharmacogenomics; G. Major Applications
France: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
Germany: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
Italy: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
Japan: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
Spain: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
U.K.: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth And Major Suppliers’ Sales And Market Shares
U.S.A.: A. Executive Summary; B. Business Environment; C. Market Structure; D. Market Size, Growth and Major Suppliers’ Sales and Market Shares
Major Product Development Opportunities: A. Instrumentation; B. Reagent Kits and Test Systems/panels; C. Computers, Software and Automation; D. Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies: A. Internal Development; B. Collaborative Arrangements; C. University Contracts; D. Distribution Strategies For Decentralized Testing Markets
Potential Market Entry Barriers And Risks: A. Market Maturity; B. Cost Containment; C. Competition; D. Technological Edge And Limitations; E. Patent Protection; F. Regulatory Constraints; G. Decentralized Testing Market Challenges
Competitive Profiles: Abbott; Aclara; Affymetrix; Agilent; Ambion; Applera; Applied Gene Technologies; Beckman Coulter; Becton Dickinson; Biokit; BioMerieux; Biotest; Boston Biomedica; Caliper; Cepheid; Chiron; Decode; Diadexus; Digene; Eiken; Enzo; Exact Sciences; Fujirebio; Gen-Probe; Gene Tec; Illumina; Innogenetics; Kreatech; Li-Cor; Molecular Diagnostics; Myriad Genetics; Nanogen; Nuvelo; Orchid Biosciences; Qiagen; Roche; Sangtec; Sequenom; Scienion; Sierra Diagnostics; Shimadzu; Takara Bio; Tepnel Life Sciences; Tecan Group; Third Wave
Appendixes: Appendix I: Major Companies Developing or Marketing NAT Reagents and Test Kits; Appendix II: Major Universities and Research Centers Developing NAT Technologies; Appendix III: Glossary of Terms; Appendix IV: Currency Exchange Rates
List of Tables: Major Companies Developing or Marketing Thermocyclers; Major Companies Developing or Marketing AIDS NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Adenovirus NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Campylobacter NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Chlamydia NAT And Other Direct Identification Tests; Major Companies Developing or Marketing CMV NAT And Other Direct Identification Tests; Major Companies Developing or Marketing EBV NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Gonorrhe NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Hepatitis NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Herpes NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Legionella NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Lyme Disease NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Mycoplasma NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Papilloma Virus NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Pneumonia NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Salmonella NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Shigella NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Streptococci NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Toxoplasmosis NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Tuberculosis NAT And Other Direct Identification Tests; Major Companies Developing or Marketing Cancer NAT Tests; Major Companies Developing or Marketing NAT Assays For Genetic Diseases; Worldwide, Laboratories Performing DNA Sequencing By Country; Worldwide, NAT Market, Potential Laboratory Universe by Country; Worldwide, NAT Volume Forecast by Country; Worldwide, NAT Market Forecast by Country; Summary Table France, NAT Volume And Sales Forecast by Major Application; France, Laboratories Performing DNA Sequencing By Market Segment; France, NAT Market Potential Laboratory Universe by Market Segment; France, NAT Volume Forecast By Major Application; France, Major Infectious Disease NAT Volume Forecast; France, Infectious Disease Screening NAT Volume Forecast; France, NAT Market Forecast By Major Application; France, Infectious Disease Screening NAT Reagent Market Forecast by Test; France, NAT Market By Major Supplier; France, HIV/Hepatitis NAT Market By Major Supplier; Summary Table Germany, NAT Volume And Sales Forecast by Major Application; Germany, Laboratories Performing DNA Sequencing by Market Segment; Germany, NAT Market Potential Laboratory Universe By Market Segment; Germany, NAT Volume Forecast By Major Application; Germany, Major Infectious Disease NAT Volume Forecast; Germany, Infectious Disease Screening NAT Volume Forecast; Germany, NAT Market Forecast By Major Application; Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test; Germany, NAT Market by Major Supplier; Germany, HIV/Hepatitis NAT Market by Major Supplier; Summary Table Italy, NAT Volume And Sales Forecast by Major Application; Italy, Laboratories Performing DNA Sequencing by Market Segment; Italy, NAT Market Potential Laboratory Universe by Market Segment; Italy, NAT Volume Forecast By Major Application; Italy, Major Infectious Disease NAT Volume Forecast; Italy, Infectious Disease Screening NAT Volume Forecast; Italy, NAT Market Forecast By Major Application; Italy, Infectious Disease Screening NAT Reagent Market Forecast by Test; Italy, NAT Market By Major Supplier; Italy, HIV/Hepatitis NAT Market By Major Supplier; Summary Table Japan, NAT Volume And Sales Forecast by Major Application; Japan, Laboratories Performing DNA Sequencing by Market Segment; Japan, NAT Market Potential Laboratory Universe by Market Segment; Japan, NAT Volume Forecast By Major Application; Japan, Major Infectious Disease NAT Volume Forecast; Japan, Infectious Disease Screening NAT Volume Forecast; Japan, NAT Market Forecast By Major Application; Japan, Infectious Disease Screening NAT Market Forecast by Test; Japan, NAT Market By Major Supplier; Japan, HIV/Hepatitis NAT Market by Major Supplier; Summary Table Spain, NAT Volume And Sales Forecast by Major Application; Spain, Laboratories Performing DNA Sequencing by Market Segment; Spain, NAT Market, Potential Laboratory Universe by Market Segment; Spain, NAT Volume Forecast by Major Application; Spain, Major Infectious Disease NAT Volume Forecast; Spain, Infectious Disease Screening NAT Volume Forecast; Spain, NAT Market Forecast By Major Application; Spain, Infectious Disease Screening NAT Reagent Market Forecast by Test; Spain, NAT Market By Major Supplier; Spain, HIV/Hepatitis NAT Market by Major Supplier; Summary Table U.K., NAT Volume And Sales Forecast by Major Application; U.K., Laboratories Performing DNA Sequencing by Market Segment; U.K., NAT Market Potential Laboratory Universe by Market Segment; U.K., NAT Volume Forecast By Major Application; U.K., Major Infectious Disease NAT Volume Forecast; U.K., Infectious Disease Screening NAT Volume Forecast; U.K., NAT Market Forecast By Major Application; U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test; U.K., NAT Market by Major Supplier; Summary Table U.S.A., NAT Volume And Sales Forecast by Major Application; U.S.A., Laboratories Performing DNA Sequencing by Market Segment; U.S.A., NAT Market, Potential Laboratory Universe by Market Segment; U.S.A., NAT Volume Forecast By Major Application; U.S.A., Major Infectious Disease NAT Volume Forecast; U.S.A., Infectious Disease Screening NAT Volume by Test Forecast; U.S.A., NAT Market Forecast By Major Application; U.S.A., Infectious Disease Screening NAT Reagent Market Forecast by Test; U.S.A., NAT Market by Major Supplier; U.S.A., HIV/Hepatitis C NAT Market By Major Supplier; U.S.A., West Nile Virus NAT Market By Major Supplier

Abstract

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.

Highlights

Business and technological trends in seven major markets
Five- and ten-year test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Profiles of market players and start-up firms developing innovative technologies and products
Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.

Geographic Coverage

France
Germany
Italy
Japan
Spain
UK
USA

Worldwide Market Overview

Laboratories performing DNA sequencing and NAT by country and market segment.
Ten-year test volume and sales projections by country.

Market Segmentation Analysis

Sales and market shares of major suppliers of NAT reagent kits and components.
Ten-year test volume and sales forecasts for major applications, including:
- Infectious Diseases
- Forensic Testing
- Cancer
- Paternity Testing/HLA Typing
- Genetic Diseases
- Others
Ten-year test volume and sales projections for over 30 NAT assays.
A comprehensive analysis of the sequencing market, by country and laboratory segment, including:
- Industrial
- Academic
- Government
- Commercial
Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers, by country.

Product/Technology Review

Comparison of leading NAT analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.
Extensive review of NAT technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
- PCR
- bDNA
- SDA
- NASBA
- TMA
- SSSR, and others
- LCR
Worldwide listings of companies, universities and research centers developing new NAT technologies and products.

Competitive Assessments

Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Comprehensive listings of companies developing and marketing NAT products, by test and application.

Opportunities and Strategic Recommendations

Specific new product development opportunities with potentially significant market appeal during the next ten years.
Design criteria for new products.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data base was conducted.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.

Get full details about this report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers

Table of Contents

Abstract

US: 800.298.5699

Int'l: +1.240.747.3093